Primary central nervous system lymphoma (PCNSL) is rare in children with immunocompromise as an important risk factor. A 7-year-old girl with unspecified T-cell immunodeficiency presented with left-sided weakness and was found to have a right-sided frontal lobe mass on imaging. The mass was resected; histopathology and molecular studies evidenced diffuse large B-cell lymphoma. Prior chest imaging had revealed left upper lobe mass, and repeat chest imaging revealed multiple pulmonary nodules, initially concerning for metastasis. Video-assisted thoracoscopic surgical wedge resection of the lung mass was performed; the molecular profile was distinct from the PCNSL, suggesting synchronous de novo lymphomagenesis of brain and pulmonary primaries.

1.
Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62: 2461–2465.
2.
Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 1986; 65: 600–607.
3.
Abla O, Weitzman S, Blay JY, O’Neill BP, Abrey LE, Neuwelt E, et al: Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res 2011; 17: 346–352.
4.
Bale JF, Wilson JF, Hill HR: Fatal histiocytic lymphoma of the brain associated with hyperimmunoglobulinemia-E and recurrent infections. Cancer 1977; 39: 2386–2390.
5.
Gregory MC, Hughes JT: lntracranial reticulum cell sarcoma associated with immunoglobulin-A deficiency. J Neurol Neurosurg Psychiatry 1973; 36: 769–776.
6.
Model LM: Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome: report of a case. Arch Neurol 1977; 34: 633–635.
7.
Zhu JQ, Hao NX, Bao WQ, Wu XR: Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child. World J Pediatr 2011; 7: 277–279.
8.
O’Neill BP, Illig JJ: Primary central nervous system lymphoma. Mayo Clin Proc 1989; 64: 1005–1020.
9.
Jain TK, Sharma P, Suman SK, Faizi NA, Bal C, Kumar R: Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings. Rev Esp Med Nucl Imagen Mol 2013; 32: 394–396.
10.
Jankowski PP, Levy ML, Crawford JR: Post-traumatic basal ganglia haemorrhage in a child with primary central nervous system lymphoma. BMJ Case Rep 2013; 2013:pii.
11.
Capra M, Wherrett D, Weitzman S, Dirks P, Hawkins C, Bouffet E: Pituitary stalk thickening and primary central nervous system lymphoma. J Neurooncol 2004; 67: 227–231.
12.
Silfen ME, Garvin JH Jr, Hays AP, Starkman HS, Aranoff GS, Levine LS, et al: Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism. J Pediatr Hematol Oncol 2001; 23: 130–133.
13.
Jones GR, Mason WH, Fishman LS, DeClerck YA: Primary central nervous system lymphoma without intracranial mass in a child. Diagnosis by documentation of monoclonality. Cancer 1985; 56: 2804–2808.
14.
Patel B, Chacko G, Nair S, Anandan J, Chacko AG, Rajshekhar V, et al: Clinicopathological correlates of primary central nervous system lymphoma: experience from a tertiary care center in South India. Neurol India 2015; 63: 77–82.
15.
MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, et al: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338: 969–973.
16.
Buckingham SC, Benaim E, Sandlund JT, Gan YJ, Freiden PJ, Behm FG, et al: Primary central nervous system lymphoma in a child with acute B-cell lymphoblastic leukaemia: consecutive Epstein-Barr virus-related malignancies. Br J Haematol 1998; 101: 345–348.
17.
Thorer H, Zimmermann M, Makarova O, Oschlies I, Klapper W, Lang P, et al: Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma. Haematologica 2014; 99:e238–e241.
18.
Makino K, Nakamura H, Yano S, Kuratsu JI: Pediatric primary CNS lymphoma: long-term survival after treatment with radiation monotherapy. Acta Neurochir (Wien) 2007; 149: 295–297.
19.
Yoon JH, Kang HJ, Kim H, Lee JW, Park JD, Park KD, et al: Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience. J Korean Med Sci 2012; 27: 1378–1384.
20.
Corry J, Smith JG, Wirth A, Quong G, Liew KH: Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 1998; 41: 615–620.
21.
Abla O, Weitzman S: Primary central nervous system lymphoma in children. Neurosurg Focus 2006; 21:E8.
22.
Quadri SA, Sobani ZA, Enam SA, Enam K, Ashraf MS: Primary central nervous system lymphoma causing multiple spinal cord compression and carcinomatous meningitis in a 6-year-old: a case report. J Pediatr Hematol Oncol 2011; 33: 312–315.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.